Yusuke Amanuma Selected Research

Yusuke Amanuma Research Topics

7	Esophageal Squamous Cell Carcinoma 01/2023 - 01/2014
5	Neoplasms (Cancer) 01/2023 - 09/2015
4	Carcinogenesis 01/2020 - 12/2015
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2020
2	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 03/2021
1	Disease Progression 01/2023
1	Ascites 01/2023
1	Esophageal Stenosis (Esophageal Stricture) 10/2021
1	Paralysis (Palsy) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Fanconi Anemia (Fanconi's Anemia) 09/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017
1	Alcoholism (Alcohol Abuse) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 09/2015

5	AcetaldehydeIBA 01/2020 - 01/2014
4	CarcinogensIBA 01/2020 - 01/2014
2	NivolumabIBA 01/2023 - 01/2023
2	Aldehyde DehydrogenaseIBA 12/2015 - 01/2014
2	Ethanol (Ethyl Alcohol)IBA 09/2015 - 01/2014
1	Taxoids (Taxanes)IBA 01/2023
1	taxaneIBA 01/2023
1	trifluridine tipiracil drug combinationIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 10/2021
1	Talaporfin (talaporfin sodium)IBA 10/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2021
1	DNA AdductsIBA 09/2017
1	involucrinIBA 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA 01/2016
1	EnzymesIBA 12/2015
1	MicroRNAs (MicroRNA)IBA 09/2015
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2015

3	Drug Therapy (Chemotherapy) 01/2023 - 12/2015
3	Radiotherapy 03/2021 - 12/2015
2	Chemoradiotherapy 10/2021 - 03/2021
2	Photochemotherapy (Photodynamic Therapy) 10/2021 - 03/2021
1	Immunotherapy 01/2023
1	Salvage Therapy 10/2021
1	Palliative Care (Palliative Therapy) 01/2020
1	Therapeutics 01/2020